1 day Ago By ABMN Staff
Align Technology, Inc. ( NASDAQ:ALGN – Get Free Report ) has been assigned a consensus rating of “Hold” from the nine brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and five have given a buy recommendation to the company.
The average 1 year price target among analysts that have issued ratings on the stock in the last year is $306.88. ALGN has been the topic of several recent analyst reports.
Piper Sandler reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Align Technology in a research note on Friday, September 13th. StockNews.
com downgraded Align Technology from a “buy” rating to a “hold” rating in a report on Sunday, September 1st. Morgan Stanley dropped their price target on Align Technology from $328.00 to $310.
00 and set an “overweight” rating for the company in a report on Thursday, July 25th. Robert W. Baird lowered their price objective on shares of Align Technology from $370.
00 to $325.00 and set an “outperform” rating for the company in a research report on Monday, July 22nd. Finally, OTR Global reiterated a “mixed” rating on shares of Align Technology in a research report on Tuesday, June 4th.
Check Out Our Latest Stock Report on ALGN Insider Activity Institutional Inflows and Outflows A number of institutional investors have recently bought and sold shares of ALGN. Gryphon Financial Partners LLC grew its holdings in shares of Align Technology by 31.0% during the fourth quarter.
Gryphon Financial Partners LLC now owns 1,396 shares of the medical equipment provider’s stock worth $383,000 after buying an additional 330 shares in the last quarter. Principal Securities Inc. bought a new stake in shares of Align Technology in the fourth quarter worth $199,000.
Dimensional Fund Advisors LP boosted its holdings in Align Technology by 3.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 213,667 shares of the medical equipment provider’s stock worth $58,548,000 after purchasing an additional 7,266 shares during the last quarter.
Janney Montgomery Scott LLC grew its position in Align Technology by 34.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 12,546 shares of the medical equipment provider’s stock valued at $3,438,000 after purchasing an additional 3,185 shares in the last quarter.
Finally, Norges Bank acquired a new stake in Align Technology in the 4th quarter valued at $223,610,000. Institutional investors own 88.43% of the company’s stock.
Align Technology Stock Down 0.1 % ALGN stock opened at $253.01 on Monday.
Align Technology has a twelve month low of $176.34 and a twelve month high of $335.40.
The company has a market cap of $19.05 billion, a PE ratio of 41.68, a price-to-earnings-growth ratio of 5.
13 and a beta of 1.64. The business’s 50-day simple moving average is $232.
28 and its 200 day simple moving average is $265.29. Align Technology ( NASDAQ:ALGN – Get Free Report ) last announced its quarterly earnings data on Wednesday, July 24th.
The medical equipment provider reported $2.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.32 by $0.
09. The company had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.
04 billion. Align Technology had a net margin of 11.34% and a return on equity of 14.
07%. The business’s revenue was up 2.6% on a year-over-year basis.
During the same quarter in the prior year, the company posted $1.73 EPS. On average, equities research analysts anticipate that Align Technology will post 7.
61 EPS for the current year. Align Technology Company Profile ( Get Free Report Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Further Reading Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter ..
